Therapeutic drug monitoring in oncology: Does it have a future?

Bioanalysis

Volumn 1, Issue 3, 2009, Pages 507-511

  McMahon, Gillian ^a   O'Connor, Robert ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG MONITORING; DRUG THERAPY; EDITORIAL; HUMAN; METHODOLOGY; NEOPLASM; ONCOLOGY;

ANTINEOPLASTIC AGENTS; DRUG MONITORING; DRUG THERAPY; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS;

EID: 79953004875     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.09.48     Document Type: Review

References (9)

1. Suthakaran C, Adithan C. Therapeutic drug monitoring-concepts, methodology, clinical applications and limitations. Health Admin. XIX(1), 22-26 (2006).
2. Mathijssen RH, de Jong FA, Loos WJ, van der Bol JM, Verweij J, Sparreboom A. Flat-fxed dosing versus body surface area-based dosing of anticancer drugs in adults: does it make a difference? Oncologist 12(8), 913-923 (2007).
3. Petrelli A, Giordano S. From single-to multi-target drugs in cancer therapy: when aspecifcity becomes an advantage. Curr. Med. Chem. 15(5), 422-432 (2008).
4. Hon YY, Evans WE. Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach. Clin. Chem. 44, 388-400 (1998).
5. Chintamani C, Singhal V, Singh JP, Lyall A, Saxena S, Bansal A. Is drug induced cytotoxicity a good predictor of response to new adjuvant chemotherapy in breast cancer? A prospective clinical study. BMC Cancer 4, 48 (2004).
6. Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ. Clinical application of the 70-gene profle: the MINDACT trial. J. Clin. Oncol. 26(5), 729-735 (2008).
7. Sparreboom A, Nooter K, Loos WJ, Verweij J. The (ir)relevance of plasma protein binding of anticancer drugs. Neth. J. Med. 59(4), 196-207 (2001).
8. Alnaim L. Therapeutic drug monitoring of cancer chemotherapy. J. Oncol. Pharm. Pract. 13(4), 207-221 (2007).
9. Rochat B, Fayet A, Widmer N et al. Imatinib metabolite profling in parallel to imatinib quantifcation in plasma of treated patients using liquid chromatography-mass spectrometry. J. Mass Spectrom. 43(6), 736-752 (2008).